Israel (2025, preliminary)
4,304.2
USD PPP per capita
+1.6% YoY
Government share
65.1
% of total (2024)
Private share
34.9
% of total (2024)
10-year change
+86.3
% since 2015

Data

Current Health Expenditure per Capita in Israel (2025) — source data. OECD.
Year USD PPP per capita YoY Change
2025 4,304.2 +1.6%
2024 4,235 +4.6%
2023 4,049 +8.7%
2022 3,724.3 +7.1%
2021 3,476.5 +15.3%
2020 3,015.4 +7.2%
2019 2,811.7 +2.3%
2018 2,749 +4.7%
2017 2,626.2 +4.0%
2016 2,524.1 +9.3%
2015 2,310 +3.2%
2014 2,237.6 unchanged
2013 2,238.5 +0.7%
2012 2,223.3 +6.8%
2011 2,081.8 +5.6%
2010 1,971.3 +3.6%
2009 1,902.8 +3.5%
2008 1,839 -0.6%
2007 1,849.6 +6.4%
2006 1,738.1 -1.0%
2005 1,756.3 +2.7%
2004 1,710 +4.5%
2003 1,636.6 -3.2%
2002 1,691.5 +2.1%
2001 1,656 +6.6%
2000 1,553.6 n/a

About this Dataset

Israel recorded 4,304.2 USD PPP per capita in current health expenditure in 2025, an OECD preliminary estimate up +69.3 from 2024's figure of 4,235.0. Spending has grown in most years since 2000, when the series started at 1,553.6 USD PPP; the steepest jump, +461.1, came in 2021, likely reflecting pandemic-related health outlays.

Government and compulsory insurance schemes typically fund most of this spending: in 2024 they covered about 65.1% of the total (2,757.0 USD PPP per capita), with voluntary insurance and household out-of-pocket payments making up the remaining 34.9% (1,478.0 USD PPP).

Compared with peer OECD economies, Israel's per-capita spending is likely still well below the OECD-38 average (roughly 70.4% of the unweighted average of about 5,755.1 USD PPP in 2023) and well below Italy (5,114.1 USD PPP) and the United States (13,932.6 USD PPP) that same year. The chart above shows the full 2000–2025 trend; the table below lists annual values with year-on-year changes.

Data sourced from the OECD System of Health Accounts (SHA) via SDMX REST API, filtered to Israel (ISR), total current health expenditure, converted to USD at purchasing power parity. The most recent year is flagged provisional by the OECD and may be revised. The OECD-38 average is an unweighted mean computed across all current OECD member countries with reported data for the comparison year.

Frequently Asked Questions

This indicator tracks total current spending on health care per person in Israel, converted to USD at purchasing power parity (PPP) so levels are comparable across countries. It covers spending by government, private insurers, and households, published annually by the OECD under its System of Health Accounts (SHA). The most recent reading is 4,304.2 USD PPP in 2025 (preliminary).

The series runs through 2025, though that year is flagged as a preliminary OECD estimate. The most recently reported prior year is 2024, at 4,235.0 USD PPP per capita. Figures are typically revised as national accounts are finalized, so both the 2024 and 2025 values may shift in future OECD updates.

Israel's 4,049.0 USD PPP in 2023 (its last year directly comparable across the OECD) sat at roughly 70.4% of the unweighted OECD-38 average of about 5,755.1 USD PPP that year. Israel also ran well below Italy (5,114.1 USD PPP in 2023) and far below the United States (13,932.6 USD PPP in 2023), though its per-capita spending has typically grown faster than many higher-spending peers over the past decade.

In 2024, government and compulsory schemes covered an estimated 2,757.0 USD PPP per capita (about 65.1% of the total), while voluntary insurance and household out-of-pocket payments accounted for roughly 1,478.0 USD PPP (about 34.9%). Government financing has typically covered close to two-thirds of current health spending in most recent years.

Per-capita spending has risen in most years since 2000, from 1,553.6 USD PPP that year to 4,304.2 USD PPP in 2025 — an increase of roughly 177% over the period, and +86.3% just since 2015. The sharpest single-year jump came in 2021, at +461.1 USD PPP, likely reflecting pandemic-related health outlays, with growth remaining elevated through 2022 (+247.9) and 2023 (+324.7) before moderating in 2024 and 2025.